Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × Educational Status × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasms 4 Fatigue 3 Sleep Wake Disorders 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Initiation and Maintenance Disorders 1 Skin Cancer Prevention 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Postoperative Complications 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Multiple Myeloma 1 Mucositis 1 Melanoma 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 24 Whole-Body Irradiation 19 Mycophenolic Acid 19 Tacrolimus 16 Busulfan 16 ruxolitinib 15 Peripheral Blood Stem Cell Transplantation 14 Antilymphocyte Serum 14 fludarabine 13 Melphalan 12 Cyclosporine 10 thymoglobulin 9 Methotrexate 9 Sirolimus 6 Etoposide 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 Azacitidine 4 pomalidomide 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 parsaclisib 2 itacitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡